Wealth Alliance Regeneron Pharmaceuticals, Inc. Transaction History

Wealth Alliance

$818 Million
Q3 2024

A detailed history of Wealth Alliance transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Alliance holds 561 shares of REGN stock, worth $393,737. This represents 0.07% of its overall portfolio holdings.

Number of Shares

561

Previous 571 1.75%

Holding current value

$393,737

Previous $600,000 1.83%

% of portfolio

0.07%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$1024.09 - $1201.76 $10,240 - $12,017	-10 Reduced 1.75%	561 $589,000
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $11,481 - $13,925	-13 Reduced 2.23%	571 $600,000
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $26,178 - $28,807	-29 Reduced 4.73%	584 $562,000
Q4 2023 Jan 30, 2024	SELL	$775.18 - $881.7 $20,154 - $22,924	-26 Reduced 4.07%	613 $538,000
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $11,079 - $13,509	-16 Reduced 2.44%	639 $525,000
Q2 2023 Aug 02, 2023	SELL	$700.03 - $830.35 $25,901 - $30,722	-37 Reduced 5.35%	655 $470,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $14,290 - $17,366	-21 Reduced 2.95%	692 $568,000
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $47,294 - $51,348	67 Added 10.37%	713 $514,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $52,805 - $66,637	92 Added 16.61%	646 $445,000
Q2 2022 Oct 11, 2022	BUY	$548.35 - $738.84 $84,445 - $113,781	154 Added 38.5%	554 $327,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $219,340 - $295,536	400 New	400 $236,000
Q1 2021 May 18, 2021	SELL	$446.73 - $548.2 $211,303 - $259,298	-473 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $11,000 - $13,983	23 Added 5.11%	473 $228,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $11,984 - $14,480	22 Added 5.14%	450 $252,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $211,140 - $275,597	428 New	428 $267,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.

Account